SRX Global Inc. (SRXH) News
Follow SRX Global Inc. (SRXH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 16 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
SRX Global and CERO 1236 SPV enter agreement to acquire CERo Therapeutics
SRX Global and CERO 1236, a wholly-owned SPV, entered into a definitive agreement to acquire CERo Therapeutics, an innovative cellular immunotherapy company developing CER 1236 for hematologic malignancies.
EQUITY | Oct 07, 2026, 07:00 PM UTC
M
SRX Global to acquire CERo Therapeutics via stock deal
SRX Global signed a stock purchase agreement to acquire CERo Therapeutics from CERo Therapeutics Holdings, issuing $1.0 million of its common stock at closing, forgiving/canceling an $8.25 million senior secured note plu
EQUITY | Oct 07, 2026, 12:13 PM UTC
L
SRXH - SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
SRXH - SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
NEWS | Sep 23, 2026, 08:05 PM UTC
M
SRX Global secures holder consent for $20 million buyback through July 2027
SRX Global entered into a Limited Consent and Amendment Agreement with required holders of its Series C Preferred to permit a stock repurchase plan. The company may buy back up to the lesser of 10,000,000 shares or 50% o
MNA | Sep 09, 2026, 07:04 PM UTC
L
SRXH - SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical -Stage Biodefense Company
SRXH - SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical -Stage Biodefense Company
EQUITY | Sep 03, 2026, 12:15 PM UTC
M
SRX Global secures $11.67M note with CERo, permits up to $6.0M advances
SRX Global completed a secured financing with CERo Therapeutics Holdings under a Consolidated Senior Secured Promissory Note dated Aug. 27, 2026, consolidating $5.67M of prior notes and permitting up to $6.0M in new adva
EQUITY | Sep 02, 2026, 08:56 PM UTC
L
SRX Global raises $2.86M in Series C preferred placement
SRX Global raised $2.86 million in a Series C preferred private placement and granted registration rights.
EQUITY | Aug 28, 2026, 09:14 PM UTC
L
SRX Global reports Fiscal Q3 2026 financial results
SRX Global Inc. (SRXH) announces its fiscal third quarter 2026 financial results.
EARNINGS | Aug 13, 2026, 08:05 PM UTC
H
SRX Global Acquires Stake in Vistagen
SRX Global buys stake in Vistagen Therapeutics
MNA | Aug 04, 2026, 09:00 AM UTC
H
SRXH - SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
SRXH - SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
MNA | Aug 03, 2026, 12:44 PM UTC
H
SRXH Acquires Shares in Jersey Mike's IPO
SRXH invests in Jersey Mike's $1 billion IPO
EQUITY | Jul 30, 2026, 06:04 PM UTC
L
SRX Global Announces Strategic Investment In Greenland Mines
SRX Global, Inc. (NYSE: SRXH ) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced a strategic investment in Greenland
EQUITY | Jul 02, 2026, 02:32 PM UTC
M
SRXH Reverse Splits
SRXH undergoes 1-60 reverse split on July 6th 2026
EQUITY | Jun 24, 2026, 11:47 AM UTC
L
SRX Global Consolidates
SRXH - SRX Global Announces Share Consolidation
EQUITY | Jun 24, 2026, 11:45 AM UTC